By Dr. Jinhag (Daniel) Baik, ophthalmologist and head director, Nunehim Eye Center (눈에힘안과의원), Guro-gu, Seoul

If you are considering surface laser vision correction in Seoul (LASEK, PRK, or a no-touch transepithelial PRK), or you had it a few months ago and things look slightly cloudy, you have probably come across the word “haze.” This guide explains what corneal haze is, how often it actually happens, and what the research does and does not show about preventing it.

Short answer: Corneal haze is a wound-healing response of the front of the cornea after surface ablation. Mild haze is common and usually fades, typically peaking around 1–3 months after surgery. Haze that reduces vision is uncommon: in a large 2017 study of 7,535 eyes treated with mitomycin C, it occurred in 1.3% of myopic eyes overall and 2.1% of highly myopic eyes. Risk rises with the size of the correction, and the first year after surgery is the period to watch.

What is corneal haze after LASEK or PRK?

Haze is a light-scattering cloudiness in the front of the cornea that forms while the cornea heals after surface ablation. It is usually faint and temporary.

In surface ablation, the surgeon removes the corneal epithelium (the thin outer skin of the cornea) and then reshapes the tissue underneath with an excimer laser. The epithelium grows back within days, but the thin epithelial basement membrane beneath it takes longer to rebuild.

According to reviews from Steven Wilson’s group (2018, 2020), when that membrane regenerates slowly or incompletely, growth factors such as TGF-β from the tears and epithelium reach the corneal stroma and drive the formation of myofibroblasts. These cells and the disorganized tissue they lay down scatter light, which is what we see as haze. The same reviews describe the reverse process: once the membrane is restored, myofibroblasts disappear and the cornea can become clear again, although this can take months or, occasionally, years.

Haze is graded on a 0–4 scale. The faintest grade (“trace”) is only visible with a slit-lamp microscope and usually does not affect vision.

How common is haze that affects vision?

Faint haze is common; haze that affects vision has been reported in roughly 1–2% of myopic eyes, higher with large corrections. Numbers differ between studies because lasers, techniques and follow-up differ.

Study Eyes / patients What was found
Lipshitz et al., 1997 (Israel) First 1,000 PRK patients Late-onset haze in 18 eyes of 17 patients (1.8%), appearing 4–12 months after surgery, with reduced vision and myopic regression
Kuo et al., 2004 (USA) 542 PRK patients Progressive haze plus regression in 10 eyes of 8 patients (1.8%); haze peaked at a mean of 7.4 months; median attempted correction −6.69 D
Kaiserman et al., 2017 (Israel) 7,535 eyes, all with mitomycin C Haze in 1.1% of low–moderate myopes, 2.1% of high myopes (> −6 D), 10.8% of hyperopic treatments; 3.5× higher with high astigmatism

What these numbers do not mean: the 1997 and 2004 figures come from early lasers before mitomycin C was routine, so they are not today’s personal risk. The 2017 study had an average follow-up of only about four months, so some late haze may have been missed. None of these figures is a promise for any individual eye.

When does haze appear, and when does it clear?

Mild haze usually peaks 1–3 months after surgery and then fades. Rarely, haze appears late, between 4 and 12 months, which is why the first year matters.

  • In 104 highly myopic eyes (−8 to −13 D), barely detectable haze peaked in the first month and had decreased by the third month (Liu et al., 2017).
  • In the 7,535-eye study, mild early haze peaked at about 69 days and severe late haze at about 115 days (Kaiserman et al., 2017).
  • In a 10–12 year follow-up of 123 PRK eyes, refraction was stable after the first year and no late-onset haze developed; wider 6 mm treatment zones had less haze than 4–5 mm zones (Rajan et al., 2006).

Who is at higher risk of haze?

The most consistent risk factor is the size of the correction (ablation depth). High myopia, high astigmatism and hyperopic treatments carry more risk.

Risk factor Evidence Strength
High myopia (> −6 D) 2.1% vs 1.1% despite mitomycin C (Kaiserman 2017) Large retrospective study
High astigmatism 3.5× higher than low astigmatism (Kaiserman 2017) Large retrospective study
Hyperopic treatment 10.8% vs 1.3% for myopia (Kaiserman 2017) Large retrospective study
Strong UV exposure All 11 late-haze eyes occurred in the high-UV season (Stojanovic 2001) Observational study
Viral conjunctivitis after surgery Late haze after infection (Pineda 1998) Single case report

A higher prescription does not automatically rule out surface ablation. It means corneal thickness, ablation depth, preventive measures and alternatives deserve a careful discussion before surgery.

Does UV light really matter, even in a Seoul winter?

One observational study links strong UV exposure to late haze, so UV protection is recommended for the first year after surgery in every season. The evidence is suggestive, not proof.

In Tromsø, Norway (70°N), where summers are bright and winters nearly dark, Stojanovic and Nitter followed PRK eyes and found that all 11 cases of late-onset haze among 314 eligible eyes occurred during high-UV periods, and none during low-UV periods. They advised UV-protective eyewear during the first postoperative year.

This was not a randomized trial, and sunglasses have not been proven to prevent haze. But UV protection is low-cost and sensible. The American Academy of Ophthalmology notes that clouds do not block UV and that UV is stronger at altitude and when reflected off water, ice or snow, so a first winter of skiing after LASEK deserves proper goggles or sunglasses labeled 100% UV or UV400.

Does mitomycin C prevent haze?

Mitomycin C (MMC), applied briefly to the cornea during surgery, reduces haze. The evidence is strongest for higher myopic corrections; benefit in low myopia is less clear.

  • A 2021 meta-analysis of 17 studies (11 randomized trials, 3,536 eyes) found MMC reduced both early and late haze, without a significant difference in endothelial cell density (Chang et al., 2021).
  • Another 2021 meta-analysis found a risk ratio for haze of 0.29 (95% CI 0.19–0.45) with MMC, but no significant difference in best-corrected vision (Ouerdane et al., 2021).
  • The American Academy of Ophthalmology’s 2015 technology assessment rated the evidence as good for higher myopic ablations, while optimal dose, benefit in low myopia and hyperopia, and long-term safety remain unestablished. Some studies reported lower endothelial cell counts, with uncertain clinical significance.

In lower prescriptions, results are mixed. In one contralateral study of transepithelial PRK up to −5.50 D, 2+ haze occurred in 2.5% of MMC eyes vs 5.0% of non-MMC eyes (not significant), and the MMC eyes lost more endothelial cells (Adib-Moghaddam et al., 2018). In another study, MMC made no difference below −3 D but reduced haze from 29.5% to 9.2% (mostly the faintest grade) at −3 to −6 D (Jin et al., 2022). In short, MMC is a tool chosen according to individual risk, not something every eye needs in the same way.

Is no-touch transepithelial PRK less likely to cause haze?

Current studies do not show that transepithelial (“no-touch”) PRK clearly reduces haze. A randomized, double-masked contralateral trial found no difference in haze between transepithelial PRK and mechanical or alcohol-assisted PRK (Hashemi et al., 2022). In high myopia, haze at 12 months was similar to alcohol-assisted PRK with MMC (Antonios et al., 2017), and one retrospective study found more trace haze with the transepithelial approach (Gadde et al., 2020). The size of the correction and post-operative care appear to matter more than the method alone.

Why are steroid eye drops prescribed, and for how long?

Steroid drops reduce the inflammatory healing response; a meta-analysis found they lower haze scores, though long courses may be unnecessary in low to moderate myopia. Pakbin et al. (2020) reported a pooled reduction in haze score of 0.20 grade overall and 0.57 grade at 3–6 months. Do not stop or extend drops on your own, and keep scheduled visits so eye pressure can be checked while you use them.

Can haze be treated if it develops?

Most faint haze needs only monitoring. Rare, dense haze that persists may be treated, with results that vary. Late haze has been reported to partly reverse with steroids or re-operation (Lipshitz 1997), but steroids or epithelial scraping did not help in three eyes in another series (Kuo 2004). In a small case series of eight eyes with persistent subepithelial fibrosis, epithelial removal with MMC was followed by no recurrence over 6–25 months (Majmudar 2000). When haze and regression occur together, surgeons usually wait for the cornea to stabilize before considering further laser treatment.

Blurry after LASEK? It is not always haze

Cause Typical timing Clue
Healing epithelium Days to weeks Vision fluctuates day to day
Dry eye after surgery Weeks to months Clears briefly after blinking; worse after screen work
Corneal haze Peaks 1–3 months; rarely 4–12 months Seen at the slit lamp; light looks scattered
Myopic regression Months later Distance vision gradually blurs; confirmed by refraction

Practical tips for office workers in Guro and Gasan Digital Complex

  • Wear sunglasses labeled 100% UV or UV400, plus a brimmed hat, for the first year, including on cloudy and winter days.
  • Pack UV-blocking goggles for your first ski trip after surgery.
  • Set phone reminders for your eye drops and keep every follow-up visit, even if you feel fine.
  • If your eye becomes red and painful, get checked promptly.
  • Blink fully and manage office heating dryness, because dry eye makes blur feel worse.

FAQ

Does everyone get haze after LASEK?
Faint haze is a common part of healing and usually fades. Haze that affects vision was reported in about 1–2% of myopic eyes in large studies, more with high myopia, high astigmatism or hyperopic treatments.

When is haze most likely?
Mild haze usually peaks 1–3 months after surgery. Rare late haze appears between 4 and 12 months, so plan follow-up through the first year.

Is the damage permanent?
Usually not. Faint haze fades, and even denser haze can clear as the basement membrane rebuilds, although a small number of eyes need further treatment.

Is no-touch transepithelial PRK better for haze?
Not clearly. Comparative studies, including a randomized trial, found similar haze rates, and one study found more trace haze with the transepithelial method.

Is mitomycin C safe, and is it always used?
Meta-analyses found less haze without a significant increase in complications or difference in vision, but long-term safety and optimal dosing are not fully established. It is most clearly useful in higher corrections and is used according to individual risk.

Do I need sunglasses in winter?
For the first year, yes. Clouds do not block UV, and snow and ice reflect it, though no trial has proven sunglasses prevent haze.

I am highly myopic. Should haze stop me from having surface ablation?
Not by itself. Risk is higher, but most haze in high-myopia studies was faint and transient. Your corneal thickness, ablation depth and options should be assessed before deciding.

Should I have a re-treatment right away if vision gets cloudy months later?
No. First identify whether the cause is dry eye, haze or regression. If haze and regression occur together, waiting for stability is usually advised.

A note from Dr. Baik

Good surface laser vision correction does not end on the day of surgery. The cornea keeps healing for about a year, and careful screening beforehand, prevention matched to your individual risk, and steady after-care (drops, UV protection and follow-up) all shape the result.

Nunehim Eye Center (눈에힘안과의원)
Head director: Jinhag (Daniel) Baik, MD, ophthalmologist
Address: 5F Kwanghee Building, 551 Siheung-daero, Guro-gu, Seoul (near Guro Digital Complex and Gasan Digital Complex)
Website: https://www.nunehim.com

Related reading on this site:

This article is educational information based on published research and professional society materials as of November 2026. It does not guarantee surgical results and does not replace an individual examination, diagnosis or treatment plan.

References

  1. Lipshitz I, et al. Late onset corneal haze after photorefractive keratectomy for moderate and high myopia. Ophthalmology. 1997;104:369–373. https://pubmed.ncbi.nlm.nih.gov/9082258/
  2. Kuo IC, et al. Late-onset corneal haze and myopic regression after photorefractive keratectomy (PRK). Cornea. 2004;23:350–355. https://pubmed.ncbi.nlm.nih.gov/15097128/
  3. Kaiserman I, et al. Corneal breakthrough haze after photorefractive keratectomy with mitomycin C: incidence and risk factors. Cornea. 2017;36:961–966. https://pubmed.ncbi.nlm.nih.gov/28542088/
  4. Stojanovic A, Nitter TA. Correlation between ultraviolet radiation level and the incidence of late-onset corneal haze after photorefractive keratectomy. J Cataract Refract Surg. 2001;27:404–410. https://pubmed.ncbi.nlm.nih.gov/11255052/
  5. Chang YM, et al. Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis. Acta Ophthalmol. 2021;99:652–662. https://pubmed.ncbi.nlm.nih.gov/33326173/
  6. Ouerdane Y, et al. Mitomycin C application after photorefractive keratectomy in high, moderate, or low myopia. Indian J Ophthalmol. 2021;69:3421–3431. https://pubmed.ncbi.nlm.nih.gov/34826969/
  7. Majmudar PA, et al. Mitomycin-C in corneal surface excimer laser ablation techniques: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122:1085–1095. https://pubmed.ncbi.nlm.nih.gov/25795477/
  8. Adib-Moghaddam S, et al. Single-step transepithelial PRK with or without mitomycin C in mild to moderate myopia. J Refract Surg. 2018;34:400–407. https://pubmed.ncbi.nlm.nih.gov/29889293/
  9. Jin L, et al. Efficacy of mitomycin C 0.02% for prevention of haze after transepithelial PRK for mild and moderate myopia. Zhonghua Yan Ke Za Zhi. 2022;58:130–136. https://pubmed.ncbi.nlm.nih.gov/35144353/
  10. Hashemi H, et al. Comparison of transepithelial and conventional PRK: a randomized contralateral trial. BMC Ophthalmol. 2022;22:68. https://pubmed.ncbi.nlm.nih.gov/35148689/
  11. Antonios R, et al. Single-step transepithelial versus alcohol-assisted PRK in high myopia. Br J Ophthalmol. 2017;101:1106–1112. https://pubmed.ncbi.nlm.nih.gov/27941045/
  12. Gadde AK, et al. Single-step transepithelial PRK vs conventional PRK in low to high myopic eyes. Indian J Ophthalmol. 2020;68:755–761. https://pubmed.ncbi.nlm.nih.gov/32317441/
  13. Pakbin M, et al. Duration of topical steroid application after PRK with mitomycin C. J Cataract Refract Surg. 2020;46:622–632. https://pubmed.ncbi.nlm.nih.gov/32271298/
  14. Rajan MS, et al. Effects of ablation diameter on long-term refractive stability and corneal transparency after PRK. Ophthalmology. 2006;113:1798–1806. https://pubmed.ncbi.nlm.nih.gov/17011958/
  15. Liu YL, et al. Visual performance after excimer laser PRK for high myopia. Taiwan J Ophthalmol. 2017;7:82–88. https://pubmed.ncbi.nlm.nih.gov/29018762/
  16. Medeiros CS, et al. The corneal basement membranes and stromal fibrosis. Invest Ophthalmol Vis Sci. 2018;59:4044–4053. https://pubmed.ncbi.nlm.nih.gov/30098200/
  17. Wilson SE, et al. Corneal epithelial basement membrane: structure, function and regeneration. Exp Eye Res. 2020;194:108002. https://pubmed.ncbi.nlm.nih.gov/32179076/
  18. Majmudar PA, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107:89–94. https://pubmed.ncbi.nlm.nih.gov/10647725/
  19. Pineda R, Talamo JH. Late onset of haze associated with viral keratoconjunctivitis following PRK. J Refract Surg. 1998;14:147–151. https://pubmed.ncbi.nlm.nih.gov/9574746/
  20. American Academy of Ophthalmology. The Sun, UV Light and Your Eyes. https://www.aao.org/eye-health/tips-prevention/sun

Leave a Reply